PixarBio unveils Non-Opiate Pain Treatments Featured on Wall-Street.com
PixarBio is using patent pending formulations of FDA approved biomaterials and FDA approved non-opiate drugs to target key neurological areas to treat pain. Thanks to their team's expertise on over 60 products approved by the FDA to start human studies, we have unmatched experience in the drug delivery system space and a track record of successfully developing FDA approved products.
- (1888PressRelease) August 23, 2016 - PixarBio is a company which specializes in the research and development of new technologies that are primarily aimed towards the treatment of pain. Established by Frank Reynods, inventor of NeuroScaffold™, the first treatment to restore function in humans after a traumatic spinal cord injury and winner of many awards such as life-time achievement award for curing paralysis from the National Spinal Injury Association, PixarBio is an industry-leader when it comes to non-opiate and non-addicting treatments for pain.
PixarBio is using patent pending formulations of FDA approved biomaterials and FDA approved non-opiate drugs to target key neurological areas to treat pain. Thanks to their team's expertise on over 60 products approved by the FDA to start human studies, we have unmatched experience in the drug delivery system space and a track record of successfully developing FDA approved products.
One of the most advanced products ever developed by PixarBio is NeuroRelease which is a morphine-strength drug that is non-opiate and non-addicting especially targeted to become a post-surgical pain drug.
Another great product developed by this company is NeuroScaffolds. It is a drug which targets neuro protection and regeneration of the spinal cord following an injury.
All in all, PixarBio is without a doubt a leader in its own field whose products are aimed towards providing successful pain treatments.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam